LINQ II Insertable Cardiac Monitor vs AVIEW
AI Verdict
Choose LINQ II Insertable Cardiac Monitor if…
Choose the Medtronic LINQ II if your primary need is long-term, continuous, and highly accurate monitoring for infrequent or asymptomatic cardiac arrhythmias. This tool is ideal for patients requiring extended cardiac surveillance (up to 4.5 years) where remote management and AI-powered detection of subtle rhythm disturbances are critical for diagnosis.
View LINQ II Insertable Cardiac Monitor →Choose AVIEW if…
Choose Coreline Soft's AVIEW AI platform if your focus is on comprehensive, AI-driven analysis of CT scans for the early detection and management of multiple thoracic diseases, including lung cancer, COPD, and coronary artery calcification. This platform is best suited for radiology departments seeking to enhance diagnostic precision, automate quantitative assessments, and streamline workflows for screening and follow-up of lung and cardiac conditions.
View AVIEW →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | LINQ II Insertable Cardiac Monitor | AVIEW |
|---|---|---|
| Pricing | Unknown | Subscription; one-off payment |
| Deployment | Subcutaneous implant with remote monitoring via mobile app or home communicator. | Cloud-based; Hybrid solution; Locally on dedicated hardware; Locally virtualized (virtual machine, Docker) |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Unknown | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
LINQ II Insertable Cardiac MonitorThe LINQ II offers a MyCareLink Heartu2122 mobile app for patient data transmission and a MyCareLink Relayu2122 home communicator, enabling remote monitoring and patient engagement. This broadens usability beyond just clinicians to include a seamless experience for patients in their daily lives. AVIEW primarily focuses on streamlining radiology workflows for clinical staff within a hospital setting.
Clinical Value
AVIEWAVIEW offers comprehensive AI-driven solutions for early detection, diagnosis, and monitoring of multiple severe thoracic conditions like lung cancer, COPD, and coronary artery calcification from CT scans. It provides detailed quantification, 3D visualizations, and workflow automation, significantly enhancing diagnostic precision across a broader range of critical diseases. LINQ II, while valuable, focuses on a single domain of cardiac arrhythmia detection.
Pricing & Value
AVIEWAVIEW offers more transparent pricing models, including subscription and one-off payment options, based on factors like the number of installations or users. This provides clearer pathways for understanding potential costs and aligning them with specific organizational needs. In contrast, LINQ II's pricing is enterprise-level and not publicly disclosed, making it harder to assess value without direct negotiation.
Enterprise Readiness
TieBoth tools exhibit strong enterprise readiness. Tool A (Medtronic) benefits from a massive installed base of over a million patients and a hybrid deployment model, demonstrating proven large-scale adoption. Tool B (AVIEW) offers highly flexible deployment options (cloud, hybrid, local, virtualized) and explicit integration with PACS/RIS/CIS, making it adaptable to diverse IT infrastructures and existing clinical workflows.
Innovation
AVIEWAVIEW demonstrates innovation by applying deep learning AI to complex multi-organ CT image analysis, providing detailed quantification for lung nodules, emphysema, and coronary artery calcification, along with 3D visualizations and automated reporting. This represents a broader and more intricate application of AI in diagnostic imaging across multiple disease states. LINQ II's innovation is focused on refining and expanding the capabilities of continuous cardiac monitoring within its specific domain.
Support & Docs
LINQ II Insertable Cardiac MonitorMedtronic provides extensive support resources for LINQ II, including patient service specialists available by phone, comprehensive clinician manuals, patient guides, and online resources for app and device connectivity. This robust ecosystem ensures both patients and healthcare providers have access to necessary assistance and information. While Coreline Soft offers technical documentation for AVIEW, its direct customer support channels are not as explicitly detailed or highlighted.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | LINQ II Insertable Cardiac Monitor | AVIEW |
|---|---|---|
| Product Name | LINQ II Insertable Cardiac Monitor | AVIEW |
| Company | Medtronic | Coreline Soft Co. |
| Core Function | Long-term, continuous heart rhythm monitoring for diagnosing arrhythmias. | Early detection, diagnosis, and monitoring of lung cancer, COPD, and coronary artery calcification from CT scans. |
| Primary Medical Specialties | Cardiology | Cardiology, Pulmonology, Radiology |
| Specific AI Algorithms/Capabilities | AccuRhythmu2122 AI algorithms for enhanced accuracy, Innovative PVC detection algorithm. | AI-powered lung nodule detection and characterization, Emphysema quantification, Coronary artery calcium (CAC) scoring. |
| Monitoring/Analysis Scope | Up to 4.5 years of continuous heart rhythm monitoring. | AI-driven diagnostic solutions for medical imaging (CT scans) for lung and cardiac conditions. |
Videos
Demos, reviews, and walkthroughs featuring LINQ II Insertable Cardiac Monitor and AVIEW.